Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

50.23
-16.3500-24.56%
Post-market: 50.470.2383+0.47%19:59 EDT
Volume:14.01M
Turnover:712.44M
Market Cap:6.19B
PE:13.36
High:57.99
Open:57.76
Low:48.10
Close:66.58
Loading ...
Aug 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jun 17, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 12, 2019

Major Issues Report

Current report, item 8.01
Jun 07, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 14, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
May 14, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans, post-effective amendments
May 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
May 03, 2019

Major Issues Report

Current report, items 5.03, 5.07, and 9.01
Aug 28, 2018

Beneficial Ownership Change

Aug 16, 2018

Beneficial Ownership Change

Jul 26, 2017

Beneficial Ownership Change

HALOZYME疗法公司
Jun 02, 2016

Beneficial Ownership Change

Jan 04, 2016

Correspondence

Jan 04, 2016

Correspondence

与美国证券交易委员会(SEC)的通信